Funded Startups in Hellerup
In Hellerup’s most recent six funded entries, Minervax’s $57M (2023-10-11) is the only disclosed round above $50M and it stands well above the rest of the…
In Hellerup’s most recent six funded entries, Minervax’s $57M (2023-10-11) is the only disclosed round above $50M and it stands well above the rest of the disclosed amounts, which range from $750K (Risk Intelligence, 2022-07-25) to $12M (BioPorto Diagnostics, 2024-06-18). The list also shows clear clustering: five of the six rounds fall between 2021-12-16 (STAC Technology) and 2024-06-18 (BioPorto Diagnostics), with the newest round dated 2026-05-22 (P-Secure). By sector, three entries are in biotech (BioPorto Diagnostics, 2024-06-18; Minervax, 2023-10-11; and BioPorto Diagnostics is biotech while P-Secure is IT and Risk Intelligence is privacy/security), creating a biotech tilt. Stage/disclosure is also concentrated: five of six rows label the round as “Series Unknown” or otherwise non-standard (including two undisclosed amounts: Nordic Solar Energy is “undisclosed” and the remaining two biotech entries are “Series Unknown”).
Most recent rounds
6 shownRelated listings
Frequently asked
What stands out by disclosed round size in Hellerup, and how does the top round compare to the rest?
Minervax’s $57M on 2023-10-11 is the largest disclosed amount, sitting far above the next-highest disclosed figure of $12M (BioPorto Diagnostics, 2024-06-18) and dwarfing smaller disclosed rounds like $3M (STAC Technology, 2021-12-16) and $750K (Risk Intelligence, 2022-07-25).
Are there noticeable date clusters among the most recent six rounds?
Yes. Five of the six entries were funded between 2021-12-16 (STAC Technology) and 2024-06-18 (BioPorto Diagnostics), while the newest outlier is P-Secure’s Seed round on 2026-05-22 at the top of the list.
Which disclosure labels dominate this Hellerup set: “Series Unknown” or “undisclosed”?
“Series Unknown” appears in three rows (Nordic Solar Energy is “Series Unknown” with an amount labeled “undisclosed”; BioPorto Diagnostics is “Series Unknown”; Minervax is “Series Unknown”), and one row is explicitly “undisclosed” (Nordic Solar Energy, 2025-04-07). Only P-Secure (Seed, $2M on 2026-05-22), Risk Intelligence (Debt Financing, $750K on 2022-07-25), and STAC Technology (Grant, $3M on 2021-12-16) provide standardized stage labels with disclosed amounts.
Is any sector over-represented among these Hellerup-funded companies?
Biotechnology is the clearest concentration with three entries: BioPorto Diagnostics ($12M on 2024-06-18) and Minervax ($57M on 2023-10-11) are biotech, alongside the sector classification shown for BioPorto-related biotech in the listing context (both biotech rows are explicitly labeled). The other sectors are single entries here: Information Technology (P-Secure), Energy (Nordic Solar Energy and STAC Technology), and Privacy and Security (Risk Intelligence).
Are there outliers that merit a closer read beyond just size?
The disclosure/series pattern is an outlier: Nordic Solar Energy (2025-04-07) is “Series Unknown” with an amount marked “undisclosed,” alongside two other biotech “Series Unknown” rounds (BioPorto Diagnostics 2024-06-18 at $12M and Minervax 2023-10-11 at $57M). Sector-wise, the only privacy/security entry is Risk Intelligence’s $750K debt financing on 2022-07-25, which sits far below the disclosed leaders.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.